Yd Bio Ltd stock is traded at $6.10, with a volume of 49,452. It is down -15.04% in the last 24 hours and down -0.81% over the past month. YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
Previous Close:
$7.18
Open:
$7.01
24h Volume:
49,452
Relative Volume:
0.49
Market Cap:
$432.14M
Revenue:
-
Net Income/Loss:
-$2.97M
P/E Ratio:
-
EPS:
-$0.988
Net Cash Flow:
-$1.18M
1W Performance:
+2.69%
1M Performance:
-0.81%
6M Performance:
+17.45%
1Y Performance:
-35.18%
1-Day Range:
$6.10$7.45
1-Week Range:
$5.69$7.45
52-Week Range:
$1.70$15.72
Yd Bio Ltd Stock (YDES) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS